Records containing: Refractory Solid Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Natural History and Biospecimen Acquisition Study for Children and Adults With Rare Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-11-10A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-10-15Phase I Study of Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children With Relapsed and Refractory Solid Tumors and Leukemias
-
CLINICAL_TRIALS study record update · 2025-03-26Single Arm Clinical Study on the Safety and Efficacy of Personalized KSX01-TCRT in Patients With Advanced Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-17Phase 1, First-in-human, Open-label Dose Escalation and Cohort Expansion Study of KB-0742 in Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2025-02-04Phase 1 Study Evaluating Genetically Modified Autologous T Cells Expressing a T-cell Receptor Recognizing a Cancer/Germline Antigen in Patients With Recurrent and/or Refractory Solid Tumors (ACTengine® IMA201-101)
-
CLINICAL_TRIALS study record update · 2024-10-31An Open-Label, Dose-Escalation/Expansion Phase 1 Study of ASP4132 Given Orally to Patients With Advanced Refractory Solid Tumors and Lymphoma
-
CLINICAL_TRIALS study record update · 2023-11-18Phase 1 Study of Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-09-11MyCustom:A Framework for Prospective and Master Protocol Trial of Precise Drug Treatment for Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-06-22A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval
-
CLINICAL_TRIALS study record update · 2023-04-13IIT Clinical Trial on Tolerance, Safety, and Preliminary Efficacy of KSX01-TCRT Injection in Solid Tumor Subjects
-
CLINICAL_TRIALS study record update · 2023-04-03A Single-arm, Prospective Clinical Study of KSH01-TCR-T in the Treatment of Refractory/Recurrent Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-09-27A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-06-15Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-06-15Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-06-15ClinicalTrials.gov study NCT02450136
-
CLINICAL_TRIALS study record update · 2022-06-15Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-06-15ClinicalTrials.gov study NCT02450123
-
CLINICAL_TRIALS study record update · 2022-02-15A Phase I/II Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-05-13Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation
-
CLINICAL_TRIALS study record update · 2020-12-22A Phase 1 With Expansion Cohort, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Intravenously Infused IT-141 in Subjects With Recurrent or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-08-11A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 in Advanced Solid Tumors and in Combination With FOLFIRI for Patients With Previously Treated Metastatic Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2020-02-11A Phase 1b Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors (ILLUMINATE-101)
-
CLINICAL_TRIALS study record update · 2019-12-30Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors